- Home
- KAVL vs XXII Comparison
KAVL vs XXII Comparison
Compare KAVL & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KAVL | XXII |
|---|---|---|
| Founded | 1998 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6M | 7.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | KAVL | XXII |
|---|---|---|
| Price | $0.14 | $1.01 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.1M | 191.6K |
| Earning Date | 09-16-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,127,037.00 | ★ $20,346,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $136.46 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 16.98 |
| 52 Week Low | $0.12 | $0.78 |
| 52 Week High | $1.55 | $287.27 |
Technical Indicators
Market Signals| Indicator | KAVL | XXII |
|---|---|---|
| Relative Strength Index (RSI) | 17.11 | 41.26 |
| Support Level | $0.47 | $1.06 |
| Resistance Level | $0.51 | $1.17 |
| Average True Range (ATR) | 0.05 | 0.09 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 5.45 | 46.94 |
Price Performance
Historical ComparisonAbout KAVL Kaival Brands Innovations Group Inc.
Kaival Brands Innovations Group Inc is focused on growing and incubating creative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.